A significant proportion of patients with type 2 diabetes mellitus have a low testosterone
level relative to reference ranges based on healthy young men. Only a small number of …

Objective Type 2 diabetes is an important risk factor for non-alcoholic fatty liver disease
(NAFLD), but current guidelines provide conflicting recommendations on whether diabetic …

Objectives To investigate the association between baseline use of glucose-lowering drugs
and serious clinical outcome among patients with type 2 diabetes. Design Territory-wide …

Diabetes is a major cause of end stage renal disease (ESRD), yet the natural history of
diabetic kidney disease is not well understood. We aimed to identify patterns of estimated …

Significance: The rising global prevalence of diabetes and its debilitating complications give
rise to significant disability and premature mortality. Due to the silent nature of diabetes and …

Background & Aims Increasing evidence suggests that non-alcoholic fatty liver disease
(NAFLD) may be an independent risk factor for chronic kidney disease (CKD). Given the …

Conclusions HDV RNA viremia is associated with a 3.8‐fold higher risk for liver‐related
outcomes. The prognosis was rather poor for patients with HDV viremia without cirrhosis at …

Background Acute myocardial infarction (AMI) is the leading cause of death among people
with diabetes mellitus (DM) and has been found to occur more frequently with extreme …

Background Polycystic ovary syndrome (PCOS) is associated with increased metabolic risk,
though data on long-term follow-up of cardiometabolic traits are limited. We postulated that …

People with type 2 diabetes (T2D) have increased cancer risk. Liver cancer (LC) has a high
prevalence in East Asia and is one of the leading causes of cancer death globally …